4.7 Article

Multifaceted roles of PTEN and TSC orchestrate growth and differentiation of Drosophila blood progenitors

Journal

DEVELOPMENT
Volume 139, Issue 20, Pages 3752-3763

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/dev.074203

Keywords

Drosophila; Lymph gland; Myeloid; TSC; PTEN; TOR

Funding

  1. National Institutes of Health [GM007185]
  2. David Geffen School of Medicine at UCLA

Ask authors/readers for more resources

The innate plasticity of hematopoietic progenitors is tightly regulated to supply blood cells during normal hematopoiesis and in response to stress or infection. We demonstrate that in the Drosophila lymph gland (LG) the tumor suppressors TSC and PTEN control blood progenitor proliferation through a common TOR- and 4EBP-dependent pathway. Tsc2 or Pten deficiency in progenitors increases TOR signaling and causes LG overgrowth by increasing the number of actively dividing cells that accumulate high levels of phosphorylated (p) 4EBP during a critical window of growth. These phenotypes are associated with increased reactive oxygen species (ROS) levels in the LG, and scavenging ROS in progenitors is sufficient to rescue overgrowth. Blood progenitor number is also sensitive to starvation and hypoxia in a TOR-dependent manner. Differences between Tsc1/2 and Pten function become apparent at later stages. Loss of Tsc1/2 autonomously increases p4EBP and decreases pAKT levels, expands the number of intermediate progenitors and limits terminal differentiation, except for a late induction of lamellocytes. By contrast, absence of PTEN increases p4EBP and pAKT levels and induces myeloproliferative expansion of plasmatocytes and crystal cells. This increased malignancy is associated with non-autonomous increases in p4EBP levels within peripheral differentiating hemocytes, culminating in their premature release into circulation and demonstrating potential non-autonomous effects of Pten dysfunction on malignancy. This study highlights mechanistic differences between TSC and PTEN on TOR function and demonstrates the multifaceted roles of a nutrient-sensing pathway in orchestrating proliferation and differentiation of myeloid-specific blood progenitors through regulation of ROS levels and the resulting myeloproliferative disorder when dysregulated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Novel association of familial testicular germ cell tumor and autosomal dominant polycystic kidney disease with PKD1 mutation

Laurel Truscott, Joanna Gell, Vivian Y. Chang, Hane Lee, Samuel P. Strom, Rex Pillai, Anthony Sisk, Julian A. Martinez-Agosto, Martin Anderson, Noah Federman

PEDIATRIC BLOOD & CANCER (2017)

Article Genetics & Heredity

IRF2BPL Is Associated with Neurological Phenotypes

Paul C. Marcogliese, Vandana Shashi, Rebecca C. Spillmann, Nicholas Stong, Jill A. Rosenfeld, Mary Kay Koenig, Julian A. Martinez-Agosto, Matthew Herzog, Agnes H. Chen, Patricia I. Dickson, Henry J. Lin, Moin U. Vera, Noriko Salamon, Damara Ortiz, Elena Infante, Wouter Steyaert, Bart Dermaut, Bruce Poppe, Hyung-Lok Chung, Zhongyuan Zuo, Pei-Tseng Lee, Oguz Kanca, Fan Xia, Yaping Yang, Edward C. Smith, Joan Jasien, Sujay Kansagra, Gail Spiridigliozzi, Mays El-Dairi, Robert Lark, Kacie Riley, Dwight D. Koeberl, Katie Golden-Grant, Shinya Yamamoto, Michael F. Wangler, Ghayda Mirzaa, Dimitri Hemelsoet, Brendan Lee, Stanley F. Nelson, David B. Goldstein, Hugo J. Bellen, Loren D. M. Pena

AMERICAN JOURNAL OF HUMAN GENETICS (2018)

Article Genetics & Heredity

Mutations in STAG2 cause an X-linked cohesinopathy associated with undergrowth, developmental delay, and dysmorphia: Expanding the phenotype in males

Sureni V. Mullegama, Steven D. Klein, Rebecca H. Signer, Eric Vilain, Julian A. Martinez-Agosto

MOLECULAR GENETICS & GENOMIC MEDICINE (2019)

Article Genetics & Heredity

Is polycystic kidney disease associated with malignancy in children?

Brian D. Friend, Kami Wolfe Schneider, Timothy Garrington, Laurel Truscott, Julian A. Martinez-Agosto, Robert S. Venick, Eileen Tsai Chambers, Patricia Weng, Douglas G. Farmer, Vivian Y. Chang, Noah Federman

MOLECULAR GENETICS & GENOMIC MEDICINE (2019)

Article Genetics & Heredity

Mutations in the sonic hedgehog pathway cause macrocephaly-associated conditions due to crosstalk to the PI3K/AKT/mTOR pathway

Steven D. Klein, Dzung C. Nguyen, Viraj Bhakta, Derek Wong, Vivian Y. Chang, Tom B. Davidson, Julian A. Martinez-Agosto

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)

Article Behavioral Sciences

The Feasibility and Outcomes of Genetic Testing for Autism and Neurodevelopmental Disorders on an Inpatient Child and Adolescent Psychiatry Service

Aaron D. Besterman, Joshua Sadik, Michael J. Enenbach, Fabiola Quintero-Rivera, Mark DeAntonio, Julian A. Martinez-Agosto

AUTISM RESEARCH (2020)

Article Genetics & Heredity

Pathogenic paternally inherited NLGN4X deletion in a female with autism spectrum disorder: Clinical, cytogenetic, and molecular characterization

Nathan Kopp, Ina Amarillo, Julian Martinez-Agosto, Fabiola Quintero-Rivera

Summary: NLGN4X is an X-linked postsynaptic scaffolding protein associated with neuropsychiatric disorders. A female proband with NLGN4X microdeletion inherited from her father showed ASD, while her father exhibited psychiatric phenotypes. This case provides further evidence that NLGN4X is sensitive to dosage changes in females.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Genetics & Heredity

Expansion of NEUROD2 phenotypes to include developmental delay without seizures

Emily K. Mis, Annalisa G. Sega, Rebecca H. Signer, Tracy Cartwright, Weizhen Ji, Julian A. Martinez-Agosto, Stanley F. Nelson, Christina G. S. Palmer, Hane Lee, Thomas Mitzelfelt, Monica Konstantino, Lauren Jeffries, Mustafa K. Khokha, Elysa Marco, Martin G. Martin, Saquib A. Lakhani

Summary: A novel de novo heterozygous NEUROD2 missense variant was found in an adolescent with developmental delay but without seizures, displaying minimal protein activity in functional testing. Another rare NEUROD2 variant identified in an adolescent with developmental delay showed normal NEUROD2 activity, suggesting that NEUROD2 variants can lead to developmental delay without early-onset seizures.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Genetics & Heredity

5q35 duplication presents with psychiatric and undergrowth phenotypes mediated by NSD1 overexpression and mTOR signaling downregulation

Fabiola Quintero-Rivera, Celeste C. Eno, Christine Sutanto, Kelly L. Jones, Malgorzata J. M. Nowaczyk, Derek Wong, Dawn Earl, Ghayda Mirzaa, Anita Beck, Julian A. Martinez-Agosto

Summary: NSD1 plays a critical role in microduplication 5q35 syndrome, potentially affecting growth and psychiatric phenotypes by altering mTOR pathway signaling. The study also suggests that leucine supplementation may serve as a potential therapeutic approach to ameliorate the symptoms.

HUMAN GENETICS (2021)

Article Genetics & Heredity

14q32.11 microdeletion including CALM1, TTC7B, PSMC1, and RPS6KA5: A new potential cause of developmental and language delay in three unrelated patients

Celeste C. Eno, Jesper Graakjaer, Dea Svaneby, Mathilde Nizon, Jessica Kianmahd, Rebecca Signer, Julian A. Martinez-Agosto, Fabiola Quintero-Rivera

Summary: Three unrelated patients have similar microdeletions of chromosome 14q32.11 with shared phenotypes, including language and developmental delay. Four overlapping genes in the deletion region are expressed in the brain and have haploinsufficiency scores, suggesting a potential influence on the resulting phenotype. This microdeletion may be associated with developmental and language delay based on the lack of normal variation in this region and the patients' similar phenotypes.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Genetics & Heredity

Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism

Thomas W. Frazier, Ritika Jaini, Robyn M. Busch, Matthew Wolf, Tammy Sadler, Patricia Klaas, Antonio Y. Hardan, Julian A. Martinez-Agosto, Mustafa Sahin, Charis Eng

Summary: This study investigated differences in PTEN pathway protein levels in PTEN-ASD, PTEN no-ASD, and macro-ASD patients, and the associations between these protein levels and neurobehavioral functions. Results showed decreased levels of PTEN and S6 in PTEN mutation groups, while reductions in MnSOD and increases in P-S6 were observed in ASD groups. The study suggests that molecular measures contribute significantly to predicting neurobehavioral outcomes.

MOLECULAR AUTISM (2021)

Article Genetics & Heredity

Toward better characterization of restricted and repetitive behaviors in individuals with germline heterozygous PTEN mutations

Mirko Uljarevic, Thomas W. Frazier, Gaelle Rached, Robyn M. Busch, Patricia Klaas, Siddharth Srivastava, Julian A. Martinez-Agosto, Mustafa Sahin, Charis Eng, Antonio Y. Hardan

Summary: This study provides a comprehensive characterization of distinct RRB domains in individuals with PTEN mutations. Significant group differences were found in RMB, IS, and CI scales, with the PTEN-No ASD group showing lower scores compared to PTEN-ASD and Macro-ASD groups. Despite limitations, important assessment and treatment implications were highlighted in this investigation.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Genetics & Heredity

Mosaic de novo SNRPN gene variant associated with Prader-Willi syndrome

Yue Huang, Katheryn Grand, Virginia Kimonis, Merlin G. Butler, Suparna Jain, Alden Yen-Wen Huang, Julian A. Martinez-Agosto, Stanley F. Nelson, Pedro A. Sanchez-Lara

Summary: The study reports the first case of PWS associated with a de novo mosaic nonsense variant of the SNRPN gene, suggesting that gene sequencing should be considered in patients with clinical suspicion of PWS.

JOURNAL OF MEDICAL GENETICS (2021)

Article Cell Biology

Bloom syndrome patients and mice display accelerated epigenetic aging

Jamie Lee, Joshua Zhang, Maeve Flanagan, Julian A. Martinez, Christopher Cunniff, Nicole Kucine, Ake T. Lu, Amin Haghani, Juozas Gordevicius, Steve Horvath, Vivian Y. Chang

Summary: Bloom syndrome (BSyn) is caused by variants in the BLM gene and manifests as poor growth, sun sensitivity, mild immunodeficiency, diabetes, and increased cancer risk, particularly leukemias. Our study reveals accelerated epigenetic aging in BSyn patients compared to carriers, as evidenced by multiple measures in blood lymphocytes. Additionally, homozygous Blm mice exhibit accelerated methylation age in various tissues according to the brain methylation clock. Overall, Bloom syndrome is associated with accelerated epigenetic aging effects in multiple tissues and significant impact on CpG methylation levels.

AGING CELL (2023)

Article Genetics & Heredity

37th Annual David W. Smith Workshop on Malformations and Morphogenesis: Abstracts of the 2016 Annual Meeting

Kim M. Keppler-Noreuil, Julian A. Martinez-Agosto, Louanne Hudgins, John C. Carey

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)

No Data Available